Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Income from Continuing Operations (2021 - 2025)

PAVmed has reported Income from Continuing Operations over the past 5 years, most recently at 2757000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 2757000.0 for Q4 2025, down 341.42% from a year ago — trailing twelve months through Dec 2025 was 2469000.0 (up 95.03% YoY), and the annual figure for FY2025 was 2469000.0, down 108.69%.
  • Income from Continuing Operations for Q4 2025 was 2757000.0 at PAVmed, up from 6011000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for PAVM hit a ceiling of 18623000.0 in Q1 2025 and a floor of 29932000.0 in Q3 2022.
  • Median Income from Continuing Operations over the past 5 years was 17408000.0 (2023), compared with a mean of 14388526.32.
  • Peak annual rise in Income from Continuing Operations hit 200.6% in 2025, while the deepest fall reached 341.42% in 2025.
  • PAVmed's Income from Continuing Operations stood at 19679000.0 in 2021, then fell by 24.86% to 24572000.0 in 2022, then grew by 29.16% to 17408000.0 in 2023, then soared by 106.56% to 1142000.0 in 2024, then plummeted by 341.42% to 2757000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 2757000.0 (Q4 2025), 6011000.0 (Q3 2025), and 12324000.0 (Q2 2025) per Business Quant data.